Archive

Archive for the ‘Independent Equity Research’ Category

RegMed Sector sags in a down market with no volume

April 3rd, 2013 No comments

The 6 W’s: Who, what, where, when, why and what of it Read more…

RegMed sector stocks trade mixed

November 12th, 2012 No comments

End of Day, Cause and Effect …  Read more…

RegMed sector has light volume with many traders out for the Veteran’s Day holiday

November 12th, 2012 No comments

The 6 W’s: Who, what, where, when, why and what of it … Read more…

RegMed Daily Dialogue, 8/12/11, the week rolls out with volatility and confidence issues

August 12th, 2011 No comments

  The 6 W’s: Who, what, where, when, why and what of it… Read more…

Stem Cell Skin Gun developed for Wound Treatment

February 11th, 2011 No comments

A new stem cell “skin gun” is being developed Read more…

LifeScience VC Investment fell steeply during Q4/10

February 10th, 2011 No comments

Life sciences venture capital (VC) investment fell steeply during Q4/10, Read more…

New Culture System for hESCs

January 27th, 2011 No comments

Scientists at UCLA have developed what they claim is a fully chemically defined, animal-free alternative to standard mouse feeder cell-and bovine sera-containing culture systems for human embryonic stem cells (hESCs). Read more…

£10M Funding, ReNeuron (LON: RENE)

December 13th, 2010 No comments

RENE will place 181.3M shares in 3 separate tranches at a price of 5.5 pence, a 17% discount to the closing price on 12/10/10 of 6.6 pence raising £10M from investors. Read more…

Creating Tissue Engineered Stem Cells to treat Disease

November 22nd, 2010 No comments

Vascular endothelial cells which line blood vessels with the ability to generate bone, cartilage and fat cells have been transformed into stem-like cells Read more…

Competition Heats Up in Macular Degeneration

November 22nd, 2010 No comments

Regeneron/Bayer’s VEGF Trap-Eye versus Genentech’s Ranibizumab … and Avastin versus Advanced Cell Technology’s stem cell therapy. Read more…